World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
37353
World Ranking
12506
National Ranking
1178

Overview

Marc Tischkowitz is affiliated with the University of Cambridge in the United Kingdom. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with substantial contributions to genetics, molecular biology, oncology, cancer research, and pathology and forensic medicine.

The scientist's work covers several main topics, including:

  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Genomics and Rare Diseases
  • DNA Repair Mechanisms
  • Global Cancer Incidence and Screening
  • Nutrition, Genetics, and Disease

Marc Tischkowitz has contributed to key publications in several venues, most frequently publishing in Genetics in Medicine and Journal of Medical Genetics, each with 16 publications. Other notable venues include bioRxiv (Cold Spring Harbor Laboratory) with 13 publications, British Journal of Cancer with 9, and Cancer Research with 8.

The scientist has collaborated extensively, with frequent co-authors including Antonis C. Antoniou, D. Gareth Evans, Clare Turnbull, Helen Hanson, and Diana Eccles.

Recent notable papers authored or co-authored by Marc Tischkowitz include:

  • Evidence for 28 genetic disorders discovered by combining healthcare and research data, 2020, Nature
  • Hereditary diffuse gastric cancer: updated clinical practice guidelines, 2020, The Lancet Oncology
  • Personalized early detection and prevention of breast cancer: ENVISION consensus statement, 2020, Nature Reviews Clinical Oncology
  • Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes, 2022, Nature
  • Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D, 2020, JNCI Journal of the National Cancer Institute

Best Publications

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips

  • Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

    Karen A Gelmon;Marc Tischkowitz;Helen Mackay;Kenneth Swenerton

  • Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

    Nasim Mavaddat;Susan Peock;Debra Frost;Steve Ellis

  • Breast-Cancer Risk in Families with Mutations in PALB2

    A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale

  • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

    Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz

  • Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

    Elena Castro;Chee Goh;David Olmos;Ed Saunders

  • Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

    Sarah Reid;Detlev Schindler;Helmut Hanenberg;Helmut Hanenberg;Karen Barker

  • Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

    Toshiyasu Taniguchi;Marc Tischkowitz;Najim Ameziane;Shirley V. Hodgson

  • Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

    Rachel S van der Post;Ingrid P Vogelaar;Fátima Carneiro;Parry Guilford

  • BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.

    Andrew Lee;Nasim Mavaddat;Amber N Wilcox;Alex P Cunningham

  • Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

    Marc Tischkowitz;Marc Tischkowitz;Jean-Sébastien Brunet;Jean-Sébastien Brunet;Louis R. Bégin;David G. Huntsman

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer

    Pardeep Kaurah;Andrée MacMillan;Niki Boyd;Janine Senz

  • Evidence for 28 genetic disorders discovered by combining healthcare and research data

    J Kaplanis;K E Samocha;L Wiel;Z Zhang

  • Hereditary breast cancer: new genetic developments, new therapeutic avenues.

    Philippe M. Campeau;William D. Foulkes;Marc D. Tischkowitz

  • Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

    Leora Witkowski;Jian Carrot-Zhang;Steffen Albrecht;Somayyeh Fahiminiya

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Whole-genome sequencing of patients with rare diseases in a national health system

    Ernest Turro;William J Astle;Karyn Megy;Stefan Graf

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

Frequent Co-Authors

William D. Foulkes
William D. Foulkes McGill University
Antonis C. Antoniou
Antonis C. Antoniou University of Cambridge
Douglas F. Easton
Douglas F. Easton University of Cambridge
D. Gareth Evans
D. Gareth Evans University of Manchester
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Diana Eccles
Diana Eccles University of Southampton
Melissa C. Southey
Melissa C. Southey Monash University
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Graham G. Giles
Graham G. Giles University of Melbourne
Anna Jakubowska
Anna Jakubowska Pomeranian Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s important to understand the alternative online degrees and healthcare pathways available. Nursing programs remain a popular choice for many students. If you’re already a registered nurse, you may want to explore the cheapest online bsn programs to advance your education without accumulating high levels of debt.

For non-nurses with a bachelor’s degree in another field, some universities offer msn direct entry programs online, allowing you to pivot into nursing in less time.

If you’re concerned about selective admission requirements, look into the easiest bsn program to get into, which can provide a less competitive pathway to a rewarding healthcare career.

Meanwhile, if you prefer working in healthcare administration, there are quality online options in medical billing and coding. Financial support is available—explore financial aid for medical billing and coding online classes to jumpstart your career journey.

Best Scientists Citing Marc Tischkowitz

Trending Scientists